This is the future of medicine
Over 17,000 participants were enrolled, and the reduction in heart attacks, strokes, and cardiovascular deaths was statistically robust and clinically meaningful, establishing significant cardiovascular protection independent of any glycemic benefit
A high extracellular glutamate concentration was one of the first xCT inhibitors described but a few years later, erastin (standing for eradicator of RAS and small T antigen-expressing cells) was identified by Stockwell's group in RAS-mutated cancer cell lines as inhibitor of xCT transport (42)
She conducts research at her institution for Boehringer Ingelheim/Lilly, Merck and Roche
code GLP1Hub for up to 20% off CHAPTERS 00:00 The bro-science problem 01:51 Meet Tanna Donalson, PA-C 03:04 What a peptide actually is 04:03 Why your GLP-1 is its own category 07:35 The legal gray area explained 09:26 The funding gap: why no one studies them 14:36 What the FDA meeting is really about 19:39 The seven peptides, one by one 29:34 Six FDA safety concerns and cancer risk 32:44 Two questions for a legit provider MORE FROM GLP-1 HUB Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show